5EUE
S1P Lyase Bacterial Surrogate bound to N-(2-((4-methoxy-2,5-dimethylbenzyl)amino)-1-phenylethyl)-5-methylisoxazole-3-carboxamide
Summary for 5EUE
Entry DOI | 10.2210/pdb5eue/pdb |
Related | 5EUD |
Descriptor | Putative sphingosine-1-phosphate lyase, ~{N}-[(1~{S})-2-[(4-methoxy-2,5-dimethyl-phenyl)methylamino]-1-phenyl-ethyl]-5-methyl-1,2-oxazole-3-carboxamide, PHOSPHATE ION, ... (4 entities in total) |
Functional Keywords | s1p lyase bacterial surrogate, lyase |
Biological source | Symbiobacterium thermophilum (strain T / IAM 14863) |
Total number of polymer chains | 2 |
Total formula weight | 112458.99 |
Authors | Argiriadi, M.A.,Banach, D.,Radziejewska, E.,Marchie, S.,DiMauro, J.,Dinges, J.,Dominguez, E.,Hutchins, C.,Judge, R.A.,Queeney, K.,Wallace, G.,Harris, C.M. (deposition date: 2015-11-18, release date: 2016-03-16, Last modification date: 2023-11-15) |
Primary citation | Argiriadi, M.A.,Banach, D.,Radziejewska, E.,Marchie, S.,DiMauro, J.,Dinges, J.,Dominguez, E.,Hutchins, C.,Judge, R.A.,Queeney, K.,Wallace, G.,Harris, C.M. Creation of a S1P Lyase bacterial surrogate for structure-based drug design. Bioorg.Med.Chem.Lett., 26:2293-2296, 2016 Cited by PubMed Abstract: S1P Lyase (SPL) has been described as a drug target in the treatment of autoimmune diseases. It plays an important role in maintaining intracellular levels of S1P thereby affecting T cell egress from lymphoid tissues. Several groups have already published approaches to inhibit S1P Lyase with small molecules, which in turn increase endogenous S1P concentrations resulting in immunosuppression. The use of structural biology has previously aided SPL inhibitor design. Novel construct design is at times necessary to provide a reagent for protein crystallography. Here we present a chimeric bacterial protein scaffold used for protein X-ray structures in the presence of early small molecule inhibitors. Mutations were introduced to the bacterial SPL from Symbiobacterium thermophilum which mimic the human enzyme. As a result, two mutant StSPL crystal structures resolved to 2.8Å and 2.2Å resolutions were solved and provide initial structural hypotheses for an isoxazole chemical series, whose optimization is discussed in the accompanying paper. PubMed: 27013389DOI: 10.1016/j.bmcl.2016.02.084 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.83 Å) |
Structure validation
Download full validation report